생분해성 스텐트 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Biodegradable Stents Market size is expected to reach USD 895.77 Million in 2034 from USD 436.70 Million (2025) growing at a CAGR of 8.31% during 2026-2034.

The global biodegradable stents market is growing rapidly as medical technology advances in cardiovascular treatments. Biodegradable stents are designed to temporarily support blocked arteries and gradually dissolve in the body after the artery heals. This reduces the long-term complications associated with traditional metal stents and improves patient recovery outcomes.

The increasing prevalence of cardiovascular diseases is a major driver of market growth. Lifestyle changes, aging populations, and rising cases of coronary artery disease are leading to more interventional cardiology procedures. Healthcare providers are adopting biodegradable stents as they offer improved safety and eliminate the need for permanent implants in some patients.

Looking ahead, the market is expected to expand as research in biomaterials and medical device technology continues to progress. Manufacturers are developing advanced biodegradable materials that provide better strength and controlled degradation. As minimally invasive cardiovascular procedures become more common, biodegradable stents will play a key role in modern heart disease treatments.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Stent Type

• Coronary Artery Stents
• Peripheral Artery Stents

By Material Type

• Polymer-based
• Metal-based

By End-user

• Hospitals
• Cardiac Catheterization Laboratories
• Ambulatory Surgery Centers

COMPANIES PROFILED

• Boston Scientific, Abbott, Elixir Medical Corporation, Kyoto Medical Planning Co Ltd, Biotronik, Terumo Corporation, Medtronic Plc, B Braun Melsungen AG, Arterial Remodeling Technologies SA, Amaranth Medical Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIODEGRADABLE STENTS MARKET: BY STENT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Stent Type
• 4.2. Coronary Artery Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Peripheral Artery Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIODEGRADABLE STENTS MARKET: BY MATERIAL TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Material Type
• 5.2. Polymer-based Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Metal-based Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIODEGRADABLE STENTS MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Cardiac Catheterization Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Ambulatory Surgery Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIODEGRADABLE STENTS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Stent Type
  • 7.2.2 By Material Type
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Stent Type
  • 7.3.2 By Material Type
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Stent Type
  • 7.4.2 By Material Type
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Stent Type
  • 7.5.2 By Material Type
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Stent Type
  • 7.6.2 By Material Type
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BIODEGRADABLE STENTS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Boston Scientific
  • 9.2.2 Abbott
  • 9.2.3 Elixir Medical Corporation
  • 9.2.4 Kyoto Medical Planning Co. Ltd
  • 9.2.5 Biotronik
  • 9.2.6 Terumo Corporation
  • 9.2.7 Medtronic Plc
  • 9.2.8 B. Braun Melsungen AG
  • 9.2.9 Arterial Remodeling Technologies SA
  • 9.2.10 Amaranth Medical Inc